全文获取类型
收费全文 | 19525篇 |
免费 | 1400篇 |
国内免费 | 96篇 |
专业分类
耳鼻咽喉 | 191篇 |
儿科学 | 532篇 |
妇产科学 | 401篇 |
基础医学 | 2184篇 |
口腔科学 | 357篇 |
临床医学 | 1702篇 |
内科学 | 4092篇 |
皮肤病学 | 327篇 |
神经病学 | 1058篇 |
特种医学 | 649篇 |
外科学 | 3458篇 |
综合类 | 726篇 |
现状与发展 | 30篇 |
一般理论 | 17篇 |
预防医学 | 1456篇 |
眼科学 | 515篇 |
药学 | 1856篇 |
中国医学 | 221篇 |
肿瘤学 | 1249篇 |
出版年
2023年 | 321篇 |
2022年 | 399篇 |
2021年 | 665篇 |
2020年 | 475篇 |
2019年 | 548篇 |
2018年 | 685篇 |
2017年 | 487篇 |
2016年 | 398篇 |
2015年 | 554篇 |
2014年 | 770篇 |
2013年 | 920篇 |
2012年 | 1307篇 |
2011年 | 1290篇 |
2010年 | 801篇 |
2009年 | 644篇 |
2008年 | 1015篇 |
2007年 | 1029篇 |
2006年 | 928篇 |
2005年 | 856篇 |
2004年 | 777篇 |
2003年 | 702篇 |
2002年 | 594篇 |
2001年 | 552篇 |
2000年 | 498篇 |
1999年 | 414篇 |
1998年 | 178篇 |
1997年 | 162篇 |
1996年 | 147篇 |
1995年 | 150篇 |
1994年 | 89篇 |
1993年 | 109篇 |
1992年 | 209篇 |
1991年 | 193篇 |
1990年 | 171篇 |
1989年 | 192篇 |
1988年 | 154篇 |
1987年 | 166篇 |
1986年 | 127篇 |
1985年 | 145篇 |
1984年 | 114篇 |
1983年 | 89篇 |
1982年 | 67篇 |
1981年 | 70篇 |
1979年 | 98篇 |
1978年 | 69篇 |
1977年 | 69篇 |
1976年 | 61篇 |
1975年 | 70篇 |
1974年 | 54篇 |
1973年 | 54篇 |
排序方式: 共有10000条查询结果,搜索用时 187 毫秒
71.
Glatiramer acetate is an immunomodulating drug used in the treatment of multiple sclerosis. It consists of a copolymer of amino acid residues in the same stoichiometric proportions as in myelin basic protein. Its mechanism of action is not entirely known and is probably multifaceted, with deletion of some immune cell populations and stimulation of others in these patients. Some mechanisms involve neuroprotectant effects. There is ample evidence of its efficacy in relapsing-remitting disease, using both clinical and imaging measures of disease activity, and in this paper we review the clinical and basic studies of this drug. Finally we discuss how some of its neuroprotectant effects may be useful in neurodegeneration such as is seen in more advanced cases of multiple sclerosis and other diseases such as amyotrophic lateral sclerosis and Parkinson’s disease. 相似文献
72.
P Iranzo MM Alsina I Martínez-De Pablo S Segura JM Mascaró C Herrero 《Journal of the European Academy of Dermatology and Venereology》2007,21(7):902-907
BACKGROUND: The mainstay of treatment for pemphigus is systemic corticosteroids. Different adjuvants have been used to reduce side-effects of long-term corticotherapy. Gold is an anti-inflammatory drug used in autoimmune diseases, whose use has waned with the advent of new immunosuppressive agents. OBJECTIVE: To study the outcome of the use of intramuscular gold treatment of pemphigus vulgaris refractory to previous therapies. METHODS: Thirteen patients with pemphigus vulgaris who had failed to respond to several prior therapies were treated with aurothiomalate, as a steroid-sparing agent. Patients were monitored to assess disease activity and gold toxicity. RESULTS: Seven patients achieved complete remission. Four patients were able to taper prednisone doses, although pemphigus flared when prednisone was discontinued or reduced. Toxicity was observed in the other two patients. CONCLUSIONS: In 53.4% of the patients, the use of chrysotherapy resulted in the complete clearing of the disease, discontinuation of all systemic therapies and induced a long-term clinical remission. Prednisone doses were able to be reduced in the remaining 46.6%. Any side-effects were reversible with drug discontinuation. Gold therapy showed efficacy as a secondary line treatment in refractory pemphigus vulgaris. 相似文献
73.
BACKGROUND: We assessed suicide and suicide attempt risk as well as symptom reduction among 3,282 depressed patients participating in duloxetine and escitalopram clinical trials assigned to either an antidepressant or placebo. METHODS: We reviewed the FDA Summary Basis of Approval reports for data regarding safety and efficacy for duloxetine and escitalopram. Furthermore, we compared suicide risk among antidepressant clinical trials in this study with our two previous analyses on seven antidepressant clinical trials. RESULTS: Suicide and suicide attempt risk varied considerably among the three analyses, showing up to ten fold differences. Interestingly, the variability exists across the three reports, rather than between treatments (antidepressants versus placebo). CONCLUSIONS: These findings suggest caution in generalizing suicide risk even from a relatively large number of participants and thus, firm conclusions can only be drawn if the number of participants is overwhelmingly large (approximately two million patients). We also noted similar magnitude of response to placebo and antidepressants among the three studies. 相似文献
74.
Abdul Rahman Arishi M. Ezzedien Rabie M. Shahid Hussain Khan Hassan Sumaili Hassan Shaabi Nabil Tadros Michael Bheem Sing Shekhawat 《JSLS, Journal of the Society of Laparoendoscopic Surgeons》2008,12(3):321-325
Spillage of gallstones may occur in the course of laparoscopic cholecystectomy. The incidence of this mishap and its consequences are variable. Ignored by many surgeons, stone spillage may be the source of significant morbidity many years after surgery. In this report, we describe the clinical course of a patient who presented with upper abdominal pain and swelling. The past history was positive for laparoscopic cholecystectomy 15 years earlier. After excision, the swelling was found to be a pseudocyst formed around spilled gallstones during a previous cholecystectomy. Apart from postoperative wound infection, the patient recovered well and remains so. Here, we discuss the problem and provide suggestions for spillage prevention and stone retrieval once spillage occurs. 相似文献
75.
Steven J. Davidson MD MBA Frank L. Zwemer Jr. MD MBA Larry A. Nathanson MD Kenneth N. Sable MD Abu N.G.A. Khan MD MS 《Academic emergency medicine》2004,11(11):1127-1134
Physician-generated emergency department clinical documentation (information obtained from clinician observations and summarized decision processes inclusive of all manner of electronic systems capturing, storing, and presenting clinical documentation) serves four purposes: recording of medical care and communication among providers; payment for hospital and physician; legal defense from medical negligence allegations; and symptom/disease surveillance, public health, and research functions. In the consensus development process described by Handler, these objectives were balanced with the consideration of efficiency, often evaluated as physician time and clinical documentation system costs, in recording the information necessary for their accomplishment. The consensus panel session participants and authors recommend that 1) clinical documentation be electronically retrievable; 2) selection and implementation be evidence-based and grounded on valid metrics (research is needed to identify these metrics); 3) the user interface be crafted to promote clinical excellence through high-quality information collection and efficient charting techniques; 4) the priorities for integration of clinical information be standardized and implemented within enterprises and across health and information systems; 5) systems use accepted standards for bidirectional, real-time clinical data exchange, without limiting the location or number of simultaneous users; 6) systems fully utilize existing electronic sources of specific patient information and general medical knowledge; 7) systems automatically and reliably capture appropriate data that support electronic billing for emergency department services; and 8) systems promote bedside documentation and mobile access. 相似文献
76.
Eight cases of spinal brucellosis are included in this study. Diagnosis was established by positive serology. Back pain was the most common complaint. Functional disturbance in walking was observed in three cases; in two others this was because of impairment of cord function. Clinical hepatosplenomegaly was found in one case. Subclinical organomegaly was diagnosed in two other patients. Psoas abscess was identified by computed tomographic scan in two separate cases. Response to drug therapy and surgical decompression, when indicated, resulted in complete recovery in all patients. 相似文献
77.
78.
D Mahalanabis H Ashraf MM Rahman GJ Fuchs 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(11):1113-1115
One-hundred and six male children aged 6-23 months with a history of acute watery diarrhoea of less than 72 h duration were randomized to receive either folic acid in a dose of 5 mg at 8-h intervals or placebo for 5 d. There were 54 children in the folic acid group and 52 in the placebo group. The admission characteristics were comparable between the two groups. No significant differences were observed in the intake of oral rehydration solution or stool output between the groups. The mean ± SD of total stool output (g kg−1 ) was 532 ± 476 vs 479 ± 354 and the duration (h) of diarrhoea was 108 ± 68 vs 103 ± 53 in the folic acid vs placebo group, respectively. The findings, therefore, should have a positive influence on preventing the inappropriate use of folic acid in acute diarrhoea. 相似文献
79.
80.